Skip to content

    KESTRA MEDICAL TECHNOLOGIES (KMTS) stock price & financials

    View KMTS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+42.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $12.78M
    $14.71M
    $15.09M
    $17.23M
    $19.37M
    +51.5%
    $22.57M
    +53.4%
    $24.55M
    +62.7%
    $28.64M
    +66.2%
    Strengthening
    Operating Profit
    -$18.43M
    -$19.13M
    -$20.60M
    -$48.21M
    -$28.88M
    -56.7%
    -$31.75M
    -66.0%
    -$34.77M
    -68.8%
    -$39.34M
    +18.4%
    Weakening
    Net Profit
    -$19.88M
    -$20.37M
    -$21.51M
    -$52.05M
    -$25.83M
    -29.9%
    -$32.78M
    -61.0%
    -$34.17M
    -58.8%
    -$38.84M
    +25.4%
    Weakening
    EPS
    $-1.12
    $-1.19
    $-1.25
    $-0.50
    +55.4%
    $-0.64
    +46.2%
    $-0.61
    +51.2%
    Strengthening
    Other Income
    Interest
    $1.87M
    $2.32M
    $1.78M
    $1.76M
    $1.91M
    +2.0%
    $1.90M
    -18.0%
    $1.89M
    +5.9%
    $1.84M
    +4.8%
    Stable
    Depreciation
    Profit before Tax
    -$20.32M
    -$20.61M
    -$21.74M
    -$51.01M
    -$25.79M
    -27.0%
    -$32.75M
    -58.9%
    -$34.13M
    -57.0%
    -$38.64M
    +24.2%
    Weakening
    MarginsOPM
    -144.2%
    -130.1%
    -136.5%
    -279.8%
    -149.1%
    -3.4%
    -140.7%
    -8.2%
    -141.6%
    -3.7%
    -137.4%
    +50.9%
    Strengthening
    Tax
    -0.0%
    -0.0%
    -0.1%
    -0.2%
    -0.1%
    -333.3%
    -0.1%
    -150.0%
    -0.1%
    -25.0%
    -0.5%
    -150.0%
    Weakening
    ReturnsROIC
    3.4%
    3.4%
    3.6%
    8.8%
    4.4%
    +29.9%
    5.5%
    +61.0%
    5.8%
    +58.8%
    6.5%
    -25.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY24FY25FY26
    AssetsCash & Equivalents$8.25M$237.59M$99.71M
    Short-Term Investments
    Total Current Assets$14.91M$255.33M$222.36M
    Net PP&E$28.39M$36.91M$62.45M
    Goodwill
    Intangibles
    Total Assets$45.95M$295.74M$358.46M
    LiabilitiesTotal Current Liabilities$32.97M$37.98M$50.37M
    Short-Term Debt
    Long-Term Debt$42.54M$41.10M$42.65M
    Long-Term Leases$2.63M$3.03M$4.11M
    Total Liabilities$78.22M$90.34M$98.81M
    EquityCommon Stock & APIC$19.91M$51.35M$58.38M
    Retained Earnings-$406.44M-$520.25M-$651.86M
    Total Equity-$209.38M$205.41M$259.66M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY24FY25FY26
    ActivitiesCash from Operating-$72.23M-$77.61M-$81.70M
    Cash from Investing-$12.23M-$23.31M-$203.28M
    Cash from Financing$77.72M$330.26M$147.09M
    SummaryCapital Expenditure-$12.23M-$22.94M-$34.89M
    Free Cash Flow-$84.46M-$100.54M-$116.59M
    FCF Margin-303.7%-168.1%-122.6%

    Ratios